We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

Research Reveals Exactly How Coughing is Triggered by Environmental Irritants

Scientists identify the reaction inside the lungs that can trigger coughing when a person is exposed to particular irritants in the air.
News

UT Southwestern Scientist Begins to Unravel What Makes Pandemic H1N1 Tick

Researchers show that the molecular makeup of the current H1N1 flu strain is strikingly different from previous H1N1 strains as well as the normal seasonal flu.
News

New Research Helps Explain Why Bird Flu has not caused a Pandemic

Bird flu viruses would have to make at least two simultaneous genetic mutations before they could be transmitted readily from human to human, study explains.
News

Researchers Find Potential Treatment for Huntington’s Disease

Better understanding of synaptic activity may support “use it or lose it” hypothesis.
News

NIH Appoints Eric D. Green, M.D., Ph.D. to be Director of The National Human Genome Research Institute

Dr. Green is currently the NHGRI scientific director and director of the NHGRI Division of Intramural Research; he will become NHGRI director on Dec. 1.
News

AgResearch to use SpectralWorks Software for Metabolomics Research

The agreement covers the supply and potential further development of AnalyzerPro® MS Data Mining Software.
News

Introduction to Automated Genomic Sample Preparation

A new eSeminar entitled 'Automating Genomics Applications on Bravo Workstations' has been announced by Agilent Automation Solutions.
News

New Combination Therapy Could Deliver Powerful Punch to Breast Cancer

A new breast cancer treatment could result from packaging one of the newer drugs, researchers say.
News

Researchers Identify Gene Mutations Underlying Risk for Most Common Form of Parkinson's Disease

International study reveals common gene variants in people of European descent.
News

BioInvent and ThromboGenics Complete Phase I Patient Trial of Anti-PlGF Cancer Therapeutic

The results, presented at the AACR-NCI-EORTC International Conference, shows that TB-403 was well tolerated with no reported dose limiting toxicity.
Advertisement